Scinai Immunotherapeutics... (SCNI)
NASDAQ: SCNI
· Real-Time Price · USD
1.68
0.15 (9.45%)
At close: Aug 21, 2025, 11:29 AM
Scinai Immunotherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.35 | -0.15 | 0.07 | -0.2 | -0.3 | -0.14 | 0.33 | -0.32 | -0.45 | -2.72 | 3.24 | -1.82 | -3.12 | 3.71 | -2.22 | -2.8 | -5.15 |
PEG Ratio | 0.00 | 0.00 | -0.00 | 0.01 | 0.01 | 0.00 | -0.00 | -0.12 | -0.00 | 0.02 | -0.02 | -0.09 | 0.01 | -0.03 | 0.09 | -0.07 | 0.10 |
PS Ratio | 3.72 | 6.38 | 17.32 | 6.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | n/a | 0.29 | -0.26 | -0.51 | -0.29 | -1.52 | -0.67 | -1.32 | -3.27 | 5.20 | 17.03 | 6.11 | 17.96 | 19.16 | 11.78 | 8.11 |
P/FCF Ratio | n/a | n/a | -1.43 | -1.06 | -1.78 | -0.91 | -1.82 | -1.46 | -2.06 | n/a | n/a | -5.99 | -19.01 | -10.09 | -12.95 | -16.73 | -43.39 |
P/OCF Ratio | n/a | n/a | -1.43 | -1.07 | -1.79 | -1.08 | -1.84 | -1.66 | -2.07 | n/a | n/a | -5.94 | -27.97 | -10.68 | -12.96 | -16.95 | -43.64 |
OCF/S Ratio | n/a | n/a | -12.13 | -6.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | 0.12 | -2.86 | -4.03 | -4.5 | -7.36 | -3.46 | -4.84 | -12.24 | 6.63 | 17.25 | 4.43 | 29.52 | 17.00 | 6.24 | 3.31 |
Quick Ratio | n/a | n/a | 1.16 | 2.19 | 2.73 | 3.06 | 4.36 | 4.12 | 4.28 | 6.15 | 5.75 | 1.71 | 5.82 | 7.30 | 0.51 | 0.61 | 0.74 |
Current Ratio | n/a | n/a | 1.16 | 2.19 | 2.73 | 3.06 | 4.36 | 4.12 | 4.28 | 6.15 | 5.75 | 1.71 | 5.82 | 7.30 | 0.51 | 0.61 | 0.74 |
Asset Turnover | n/a | n/a | 0.01 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -110.03 | -61.16 | -1.28 | 13.46 | -8.79 | -3.56 | n/a | 7.77 | -9.78 | n/a | 0.60 | -17.26 | -10.94 | 8.90 | -2.95 | -3.26 | -2.53 |
Return on Equity | n/a | n/a | 1.05 | 0.32 | 0.42 | 0.51 | -1.15 | 0.53 | 0.73 | 0.30 | 0.40 | -2.34 | -0.49 | 1.21 | -2.16 | -1.05 | -0.39 |
Return on Assets | n/a | n/a | 0.85 | -0.16 | -0.13 | -0.13 | 0.17 | -0.19 | -0.15 | -0.02 | 0.05 | -0.12 | -0.08 | 0.04 | -0.11 | -0.14 | -0.09 |
Return on Invested Capital | n/a | n/a | -0.22 | 0.29 | -0.13 | -0.11 | -0.12 | 0.49 | -0.15 | 0.17 | 0.05 | -0.14 | -0.1 | 0.26 | -0.11 | -0.11 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -0.81 | -1.48 | -0.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -2.66 | -10.83 | 62.23 | -8.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -10.69 | 62.23 | -8.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -2.07 | -10.99 | -14.4 | 13.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -2.05 | -8.09 | 65.39 | -5.39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |